Skip to main content
Howard Welgus, MD, Dermatology, Ballwin, MO

HowardWelgusMD

Dermatology Ballwin, MO

Welgus Consulting LLC

Dr. Welgus is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Welgus' full profile

Already have an account?

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Dermatology, 1978 - 1981
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 1977 - 1978
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 1977

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 1999 - 2026
  • American Board of Dermatology Dermatology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Trial of Roflumilast Cream for Chronic Plaque Psoriasis  
    Leon H Kircik, Steven E Kempers, Howard Welgus, The New England Journal of Medicine

Authored Content

  • Trial of Roflumilast Cream for Chronic Plaque PsoriasisJuly 2020

Press Mentions

  • Arcutis Appoints Patrick Burnett, M.D., Ph.D., FAAD, as Chief Medical Officer
    Arcutis Appoints Patrick Burnett, M.D., Ph.D., FAAD, as Chief Medical OfficerJuly 27th, 2020
  • Jiangsu Hengrui Medicine and Arcutis Announce a Development and Commercialization Partnership for Novel Immune-Mediated Dermatology Therapy Using SHR0302
    Jiangsu Hengrui Medicine and Arcutis Announce a Development and Commercialization Partnership for Novel Immune-Mediated Dermatology Therapy Using SHR0302January 5th, 2018